In the cases where we've suggested there could be compensation, in both the dairy and the pharmaceutical cases, those are very difficult to predict from where we are now.
The minister mentioned that after CETA comes into effect, we've still got at least an eight- to ten-year period before we would first start to see some of those products coming off patent protection. We don't know what kind of drugs will be in the system exactly at that point. If there are blockbuster drugs, some of the ones we've seen in the past, then we could see more significant impacts. If there don't happen to be blockbuster drugs, then the impacts will be much less. It doesn't factor in what else is going to happen in domestic policy with respect to patents on pharmaceuticals, at either the federal or provincial levels.
When we talk about patents, we're going to be discussing with provinces and territories in the coming months what kind of approach makes the most sense. I certainly wouldn't want to predict the outcome of that ahead of time, given that's an open dialogue in consultation.
Similarly, when it comes to the dairy side, again we're not sure exactly what kind of impact will occur, because consumption of cheese in particular is continually rising. The economic hit may be fairly minimal if that trend continues, so we would want to see what happens there.
As with pharma, we are talking to provinces and territories about how that process would be designed. We're also holding consultations with the dairy industry to get its views. I wouldn't want to prejudge any of that or attempt to suggest we could put dollar figures on it before we know what the design is.